[HTML][HTML] Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective …
Q Yu, Z Li, Y Liu, Y Luo, J Fan, P Xie, X Cao, X Chen… - Current …, 2023 - mdpi.com
(1) Background: The duration of adjuvant chemotherapy recommended by the NCCN
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study …
Q Yu, Z Li, Y Liu, Y Luo, J Fan, P Xie… - Current oncology …, 2023 - pubmed.ncbi.nlm.nih.gov
(1) Background: The duration of adjuvant chemotherapy recommended by the NCCN
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
[HTML][HTML] Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective …
Q Yu, Z Li, Y Liu, Y Luo, J Fan, P Xie, X Cao… - Current …, 2023 - ncbi.nlm.nih.gov
Background: The duration of adjuvant chemotherapy recommended by the NCCN
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study …
Q Yu, Z Li, Y Liu, Y Luo, J Fan, P Xie, X Cao… - Current …, 2023 - search.ebscohost.com
Background: The duration of adjuvant chemotherapy recommended by the NCCN
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
[PDF][PDF] Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study …
Q Yu, Z Li, Y Liu, Y Luo, J Fan, P Xie, X Cao… - Curr …, 2023 - pdfs.semanticscholar.org
(1) Background: The duration of adjuvant chemotherapy recommended by the NCCN
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
Effect of Different Durations of Adjuvant Capecitabine Monotherapy on the Outcome of High-Risk Stage II and Stage III Colorectal Cancer: A Retrospective Study …
Q Yu, Z Li, Y Liu, Y Luo, J Fan, P Xie, X Cao… - Current Oncology …, 2023 - europepmc.org
Background: The duration of adjuvant chemotherapy recommended by the NCCN
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …
guidelines is 6 months. However, patients are not compliant with intravenous chemotherapy …